Human

Infectious Disease

86 drugs in development·46 companies·1 clinical trial

Drug Pipeline by Phase

Approved(20)

Drug	Company
darunavir	Mylan II B.V. (MYL)
ebanga	SAB BIOTHERAPEUTICS, INC. (SABS)
etravirine	Amneal Pharmaceuticals, Inc. (AMRX)
fosamprenavir	Mylan II B.V. (MYL)
Humalog® (and Humalog variants)	ELI LILLY & Co (LLY)
Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500	ELI LILLY & Co (LLY)
ibrance	PFIZER INC (PFE)
imuldosa	Acorda Therapeutics, Inc. (ACOR)
kirsty	Bone Biologics Corp (BBLG)
kisqali femara co-pack	Novartis AG (NVS)
nevirapine	Mylan II B.V. (MYL)
ngenla	PFIZER INC (PFE)
PrepaCyte® CB Processing System	Cryo-Cell International Inc. (CCEL)
semglee	Mylan II B.V. (MYL)
skytrofa	Ascendis Pharma A/S (ASND)
tembexa	Emergent BioSolutions Inc. (EBS)
trodelvy	Immunome Inc. (IMNM)
tykerb	Novartis AG (NVS)
wezlana	AMGEN INC (AMGN)
yesintek	Bone Biologics Corp (BBLG)

Phase 3(8)

Drug	Company
Antineoplastons (A10 & AS2-1)	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
biological/vaccine	BioNTech SE (BNTX)
Doravirine	Merck & Co., Inc. (MRK)
Emtricitabine/tenofovir disoproxil	Merck & Co., Inc. (MRK)
ISL	Merck & Co., Inc. (MRK)
MK-8527	Merck & Co., Inc. (MRK)
posoleucel	Kalaris Therapeutics, Inc. (KLRS)
ULO	Merck & Co., Inc. (MRK)

Phase 2(20)

Drug	Company
2 NRTIs	Merck & Co., Inc. (MRK)
BIC/FTC/TAF	Merck & Co., Inc. (MRK)
bIRV	BioNTech SE (BNTX)
Combined LAI Treatment	COLLEGIUM PHARMACEUTICAL, INC (COLL)
dare-hpv	Dare Bioscience, Inc. (DARE)
DOR/3TC/TDF	Merck & Co., Inc. (MRK)
eseba-vec	HOOKIPA Pharma Inc. (HOOK)
FOLFIRI regimen	Crinetics Pharmaceuticals, Inc. (CRNX)
Gardasil 9	Crinetics Pharmaceuticals, Inc. (CRNX)
Goserelin	ENANTA PHARMACEUTICALS INC (ENTA)
Iparomlimab and Tuvonralimab	Merus N.V. (MRUS)
ISL/ULO	Merck & Co., Inc. (MRK)
ivx-241	Icosavax, Inc. (ICVX)
lopinavir / ritonavir	Dare Bioscience, Inc. (DARE)
qIRV	BioNTech SE (BNTX)
QIV	BioNTech SE (BNTX)
tIRV	BioNTech SE (BNTX)
tnx-1500	Tonix Pharmaceuticals Holding Corp. (TNXP)
Vorinostat	UNITED THERAPEUTICS Corp (UTHR)
VTP-200	Barinthus Biotherapeutics plc. (BRNS)

Phase 1(19)

Drug	Company
ADXS-HER2 (ADXS31-164)	Ayala Pharmaceuticals, Inc. (ADXS)
alvr106	Kalaris Therapeutics, Inc. (KLRS)
arct-2304	Arcturus Therapeutics Holdings Inc. (ARCT)
CB-708 (ATG-037)	Calithera Biosciences, Inc. (CALA)
control vaccine older adults	Arcturus Therapeutics Holdings Inc. (ARCT)
control vaccine younger adults	Arcturus Therapeutics Holdings Inc. (ARCT)
COVID-19 Vaccine	BioNTech SE (BNTX)
CT-0525	Carisma Therapeutics Inc. (CARM)
hb-500	HOOKIPA Pharma Inc. (HOOK)
hb-502	HOOKIPA Pharma Inc. (HOOK)
Investigational Influenza Vaccine	BioNTech SE (BNTX)
keyhole limpet hemocyanin	Tonix Pharmaceuticals Holding Corp. (TNXP)
Licensed Influenza Vaccine 1	BioNTech SE (BNTX)
Licensed Influenza Vaccine 2	BioNTech SE (BNTX)
Mebendazole (improved formulation)	Bullfrog AI Holdings Inc. (BFRG)
MGD014	UNITED THERAPEUTICS Corp (UTHR)
MGD014	MACROGENICS INC (MGNX)
MGD020	MACROGENICS INC (MGNX)
MGD020	UNITED THERAPEUTICS Corp (UTHR)

Preclinical(4)

Drug	Company
Astatine-211 program	Cellectar Biosciences, Inc. (CLRB)
cannabis-derived compounds	WEED, INC. (BUDZ)
Lead-212 program	Cellectar Biosciences, Inc. (CLRB)
license ip products	ENTEST GROUP, INC. (ETNI)

Unknown(7)

Drug	Company
AVIPure CH1 (Fab capture resin)	REPLIGEN CORP (RGEN)
Cannabis Genomic Study (Sangre AT, LLC)	WEED, INC. (BUDZ)
ImmunoPass	AXIM BIOTECHNOLOGIES, INC. (AXIM)
iPScelz™ (iPSC program)	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
npulse vybrance percutaneous electrode system	Pulse Biosciences Inc Common Stock (DE) (PLSE)
Precision DNA libraries	Twist Bioscience Corp (TWST)
ProLectin-Rx	BIOXYTRAN, INC (BIXT)

Phase 1/Phase 2(6)

Drug	Company
IMC-M113V	Immunocore Holdings plc (IMCR)
investigational hmpv vaccine	Sanofi (SNY)
investigational hmpv/rsv vaccine	Sanofi (SNY)
investigational rsv vaccine	Sanofi (SNY)
investigational rsv+hmpv vaccine	Sanofi (SNY)
licensed rsv vaccine	Sanofi (SNY)

Phase 2/Phase 3(1)

Drug	Company
PRO 140	CytoDyn Inc. (CYDY)

Phase 4(1)

Drug	Company
bictegravir/emtricitabine/tenofovir alafenamide	GH Research PLC (GHRS)

BioSniper tracks 86 drugs in development for Human across 46 companies.

There are 1 clinical trial targeting Human tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.